Academic Journal
Q1International Journal of Molecular Medicine
About International Journal of Molecular Medicine
About International Journal of Molecular Medicine
International Journal of Molecular Medicine is a peer-reviewed scholarly journal published by Spandidos Publications (Greece). It focuses on Q1. Publication coverage spans 1998-2026.
Key indicators: ISSN 1791-244X, 1107-3756; H-index 124.
Understanding This Journal's Metrics
Journal metrics help researchers assess fit, but they must be interpreted in context:
- H-index (124): Exceptionally high — 124 articles have each been cited at least 124 times. This indicates deep, sustained influence in the field.
Publishing in International Journal of Molecular Medicine
An established venue in its field. The journal welcomes solid, well-executed research. Ensure your manuscript fits the stated scope and follows author guidelines carefully.
- Scope fit: Confirm your research aligns with Q1. Off-scope manuscripts are typically desk-rejected quickly.
- Author guidelines: Follow formatting, reference style, and article-type requirements exactly — non-compliant manuscripts may be returned without review.
Is This Journal Right for Your Paper?
- Audience match: Will the journal's readers cite and build on your findings?
- Timeline: Higher-tier journals mean longer review and higher rejection risk. Balance prestige against your schedule.
- Indexing: Confirm indexing in Web of Science, Scopus, and PubMed (if biomedical) meets your institutional requirements.
- Open access needs: Check funder mandates and whether the journal offers compliant OA options.
Frequently Asked Questions
What is the ISSN of International Journal of Molecular Medicine?
1791-244X, 1107-3756.
Who publishes International Journal of Molecular Medicine?
Spandidos Publications.
What are International Journal of Molecular Medicine's metrics?
H-index 124.
Is International Journal of Molecular Medicine peer-reviewed?
Yes — it is a peer-reviewed scholarly journal indexed in major academic databases.
Source-backed journal facts
Topics in published research
MicroRNA in disease regulation; Cancer-related molecular mechanisms research; Circular RNAs in diseases; RNA modifications and cancer; Autophagy in Disease and Therapy; Immune Response and Inflammation.
OpenAlex classifies topics from published works. These topics are not the publisher’s official aims and scope.
Source: OpenAlex source record. Retrieved 2026-10-03. Source record updated 2026-10-02. OpenAlex metrics are different from SCImago metrics and the Clarivate Journal Impact Factor.
Journal Metrics
Quartile, SJR and the listed SCImago H-index use the 2025 imported SCImago dataset. A quartile may vary by subject category. Values without a source or reporting year are unverified historical entries. Verify the current Journal Impact Factor with Clarivate or the publisher before using it.
Aims & Scope
The publisher’s official aims and scope have not yet been verified for this profile. Use the journal website to check subject fit and accepted article types before submitting.
Recent Research Articles
Latest publications matched automatically by ISSN.
[Expression of Concern] EETs and CYP2J2 inhibit TNF‑α‑induced apoptosis in pulmonary artery endothelial cells and TGF‑β1‑induced migration in pulmonary artery smooth muscle cells
Wenjing Feng, Xizhen Xu, Gang Zhao, Geng Li et al.
2026-10-12 · DOI: 10.3892/ijmm.2026.6012Multi‑target mechanisms of paeoniflorin in inflammatory regulation: A network pharmacology (Review)
Jin Zhang, Junjie Ye, Kun Jin, Xuan Sun et al.
2026-10-09 · DOI: 10.3892/ijmm.2026.6010Gomisin A as a multi‑target therapeutic agent: Pharmacological mechanisms, pharmacokinetics and network pharmacology (Review)
Jiaqi Xu, Sha Shi, Chengkai Zhu, Qi Sui et al.
2026-10-09 · DOI: 10.3892/ijmm.2026.6011[Expression of Concern] Gambogic acid inhibits invasion of osteosarcoma via upregulation of TIMP‑1
Zeng-Feng Xin, Cheng-Chun Shen, Li-Jiang Tao, Shi-Gui Yan et al.
2026-10-08 · DOI: 10.3892/ijmm.2026.6008Mechanisms of neuroimmune crosstalk in vestibular disorders: Linking inflammation with neural circuit dysfunction (Review)
Xianfang Pan, Jin Fan, Zhiyi Yang, Zegang Yin et al.
2026-10-08 · DOI: 10.3892/ijmm.2026.6009Anesthetics and cancer biology: Translational evidence from perioperative modulation to drug repurposing (Review)
Ting Yang, Jiao Tang, Muhammad Mudabbar, Huan Hu et al.
2026-10-05 · DOI: 10.3892/ijmm.2026.6007[Expression of Concern] Multiple roles of SOCS proteins: Differential expression of SOCS1 and SOCS3 in atherosclerosis
Xiao Liang, Ming He, Tao Chen, Yan Liu et al.
2026-09-30 · DOI: 10.3892/ijmm.2026.6006Spatial multi‑omics identifies an SPP1+ macrophage‑driven anti‑apoptotic niche in osteoarthritis synovium via the SPP1‑CD44 axis
Han Gong, Hao Shen, Feng Zhang, Wei Wang et al.
2026-09-29 · DOI: 10.3892/ijmm.2026.6005Novel insights into the role of the renal interstitial microenvironment in Randall's plaque formation (Review)
Jialiang Wang, Zhangcheng Liao, Minghui Liu, Yizhou Wang et al.
2026-09-29 · DOI: 10.3892/ijmm.2026.6004[Corrigendum] Alteration of the Wnt/GSK3β/β‑catenin signalling pathway by rapamycin ameliorates pathology in an Alzheimer's disease model
Jingfei Chen, Zhimin Long, Yanzhen Li, Min Luo et al.
2026-09-28 · DOI: 10.3892/ijmm.2026.6003miR‑222‑3p inhibits diabetic skin wound healing by targeting APLN
Ruyan Jie, Ying Tang, Tingting Wu, Chenfan Zhang et al.
2026-09-25 · DOI: 10.3892/ijmm.2026.6002Salidroside attenuates myocardial ischemia‑reperfusion‑induced oxidative stress and ferroptosis by promoting USP11‑mediated deubiquitination of PRDX2
Zhi-Cong Qiu, Jian-Nan Li, Yi-Zhou Li, Zi-Ming Wu et al.
2026-09-23 · DOI: 10.3892/ijmm.2026.6000Reprogramming of cell death in gastric cancer: From molecular mechanisms to therapeutic potential (Review)
Mengru Liu, Zhujun Wu, Qiao Chen, Weiguo Ni et al.
2026-09-23 · DOI: 10.3892/ijmm.2026.5999[Corrigendum] Adjudin delays cellular senescence through Sirt3‑mediated attenuation of ROS production
Keyi Geng, Ningzhen Fu, Xiao Yang, Weiliang Xia et al.
2026-09-23 · DOI: 10.3892/ijmm.2026.6001Remimazolam attenuates myocardial ischemia/reperfusion injury by inhibiting ferroptosis involving the AKT/SLC7A11/GPX4 axis
Xiyuan Chen, Jianghong Zhao, Xingtong He, Yuqi Zhang et al.
2026-09-22 · DOI: 10.3892/ijmm.2026.5998Tumor‑immune spatiotemporal co‑evolution: A new paradigm for understanding and overcoming therapy resistance in metastatic castration‑resistant prostate cancer (Review)
Li Yan, Xiaoke Sun, Pengxiao Su
2026-09-21 · DOI: 10.3892/ijmm.2026.5997Research progress on the role of IL‑37 in gynecological and obstetrics‑related diseases (Review)
Hongjing Wang, Renukha Arjune, Weiyu Gan, Na Guo et al.
2026-09-21 · DOI: 10.3892/ijmm.2026.5996[Expression of Concern] PAT protein mRNA expression in primary rat hepatocytes: Effects of exposure to fatty acids
Elena Grasselli, Adriana Voci, Carlo Pesce, Laura Canesi et al.
2026-09-21 · DOI: 10.3892/ijmm.2026.5995Neutrophil extracellular traps in cardiovascular disease: Mechanisms and therapeutic implications (Review)
Zhao Wang, Mingde Chang, Wenyu Shang, Yunfeng Jia et al.
2026-09-18 · DOI: 10.3892/ijmm.2026.5994Sirt1 attenuates calcific aortic valve disease by inhibiting ferroptosis and enhancing mitochondrial function via the activation of the Nrf2/HO‑1/FTH1 axis
Fei Yan, Lei Shi, Yuechan Wang, Ying Zhao et al.
2026-09-18 · DOI: 10.3892/ijmm.2026.5993Reviews
Community Reviews
Version History
October 9, 2026 at 7:10 pm
September 25, 2026